(Q44188017)

English

In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Alzheimer's disease

0 references

0 references

author name string

Takekazu Kubo

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Satoko Nishimura

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Yoshihiro Kumagae

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Isao Kaneko

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Journal of Neuroscience Research

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

474-483

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Methods for staining amyloid in tissues: a review

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Chemical modifications of deposited amyloid-beta peptides

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Alzheimer's disease: a re-examination of the amyloid hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Biochemistry of altered brain proteins in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Neuritic plaque amyloid in Alzheimer's disease is highly racemized

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Identifiers

10.1002/JNR.10391

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44188017&oldid=2108358176"